local_hospital

HNO Praxis Dreieich

Address
Heckenweg 3, 63303 Dreieich, Germany

HNO Praxis Dreieich - Allergic Rhinitis & Immunotherapy Research Center

HNO Praxis Dreieich is a specialized otolaryngology practice dedicated to advancing the understanding and treatment of allergic respiratory conditions. The center demonstrates significant expertise in conducting clinical trials focused on allergen-specific immunotherapy and allergic rhinoconjunctivitis management, with particular emphasis on pediatric and adult populations.

  • Birch pollen-induced allergic rhinitis and rhinoconjunctivitis research across multiple age groups
  • Subcutaneous immunotherapy (SCIT) trials evaluating novel allergoid formulations
  • House dust mite (HDM) allergy treatment studies in patients with moderate to severe symptoms
  • Sublingual immunotherapy (SLIT) efficacy and safety assessments in children and adolescents

The center's research portfolio reflects a comprehensive approach to allergen immunotherapy development, including both subcutaneous and sublingual administration routes. Their involvement in Phase IIIb multicenter trials demonstrates capacity for rigorous placebo-controlled studies evaluating seasonal and perennial allergen immunotherapy, with expertise in measuring combined symptom and medication scores as primary efficacy endpoints.

Site Overview

assignment
5
connected trials
corporate_fare
5
sponsors
science
49
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
5
Total trials linked
Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 1 therapeutic areas and 15 of 49 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years

Top 40 of 49 compounds, ranked by number of trials.

lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
5
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
5
Outperforms 72% of sites
public
Therapeutic diversity
1areas
Outperforms 2% of sites
groups
Sponsor diversity
5sponsors
Outperforms 76% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in HNO Praxis Dreieich

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Randomized, Double-Blind, Placebo-Controlled Study of Subcutaneous Mannan-Conjugated Betula Pendula Pollen Allergoid in Birch Pollen-Induced Allergic RhinitisCCDRD Cooperative Clinical Drug Research and Development AG, ClinCompetence Cologne GmbH, Inmunotek S.L.Phase IIINot RecruitingFeb 2024Jun 2024

IMP list

lock Showing 1 of 49 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Cat Epithelia3Unknown2024-08-222026-06-01

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.